Alkenyldiarylmethane non-nucleoside hiv-1 reverse...

C - Chemistry – Metallurgy – 07 – C

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07C 62/32 (2006.01) A61K 31/34 (2006.01) A61K 31/41 (2006.01) A61K 31/42 (2006.01) A61K 31/535 (2006.01) C07C 62/34 (2006.01) C07C 63/38 (2006.01) C07C 65/11 (2006.01) C07C 65/24 (2006.01) C07C 65/28 (2006.01) C07C 69/76 (2006.01) C07C 69/94 (2006.01) C07C 317/46 (2006.01) C07C 323/16 (2006.01) C07C 323/62 (2006.01) C07D 263/32 (2006.01)

Patent

CA 2317942

Alkenyldiarylmethane (ADAM) compounds have been found effective as anti-HIV agents. Novel ADAM compounds, their pharmaceutical formulations and a method of using same to treat viral infections are described.

On a découvert que des composés d'alcényldiarylméthane (ADAM) sont efficaces en tant qu'agents anti-VIH. On décrit dans cette invention de nouveaux composés ADAM, des compositions pharmaceutiques contenant ces derniers ainsi qu'un procédé d'utilisation de ces mêmes composés pour traiter des infections virales.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Alkenyldiarylmethane non-nucleoside hiv-1 reverse... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Alkenyldiarylmethane non-nucleoside hiv-1 reverse..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Alkenyldiarylmethane non-nucleoside hiv-1 reverse... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1466467

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.